NCT00254449View on ClinicalTrials.gov

Effect of NGX-4010 on ENFD and Sensory Function

PHASE1CompletedINTERVENTIONAL

Enrollment

36

Participants

Timeline

Start Date

November 30, 2005

Study Completion Date

May 31, 2006

Conditions

Human Volunteers

Interventions

DRUG

NGX-4010

Trial Locations (1)

55455

NeurogesX Investigational Site, Minneapolis

Sponsors

Lead Sponsor

All Listed Sponsors

lead

NeurogesX

INDUSTRY